Cited by 930Sirtuins and Resveratrol in MedicineGenetics, Aging, and Longevity in Model OrganismsAdipose Tissue and Metabolism

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice

Open access

Abstract

NAD+ availability decreases with age and in certain disease conditions. Nicotinamide mononucleotide (NMN), a key NAD+ intermediate, has been shown to enhance NAD+ biosynthesis and ameliorate various pathologies in mouse disease models. In this study, we conducted a 12-month-long NMN administration to regular chow-fed wild-type C57BL/6N mice during their normal aging. Orally administered NMN was quickly utilized to synthesize NAD+ in tissues. Remarkably, NMN effectively mitigates age-associated physiological decline in mice. Without any obvious toxicity or deleterious effects, NMN suppressed age-associated body weight gain, enhanced energy metabolism, promoted physical activity, improved insulin sensitivity and plasma lipid profile, and ameliorated eye function and other pathophysiologies. Consistent with these phenotypes, NMN prevented age-associated gene expression changes in key metabolic organs and enhanced mitochondrial oxidative metabolism and mitonuclear protein imbalance in skeletal muscle. These effects of NMN highlight the preventive and therapeutic potential of NAD+ intermediates as effective anti-aging interventions in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2016.09.013

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 45 references

Cited by

Sorted by citations

Items 901–930 of 930

Metadata

Authors
Mills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., Yoshino, J., & Imai, S.-I.
Affiliations
  • Washington University in St. Louis (US)
  • Oriental Yeast Co., Ltd. (Japan) (JP)
  • Queen's University Belfast (GB)
Corresponding author
  • Yoshino, Jun
  • Imai, Shin-ichiro
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2016-12
Volume
24
Issue
6
Pages
795-806
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2546015443
Cited by
930
References
45
Citations by year
2026: 127 · 2025: 134 · 2024: 127 · 2023: 96 · 2022: 106 · 2021: 111 · 2020: 74 · 2019: 63 · 2018: 58 · 2017: 31 · 2016: 1
FWCI
29.38
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
Funders
  • Diabetes Research Center (P30 DK020579)
  • Nutrition Obesity Research Center (P30 DK56341)
  • Research to Prevent Blindness Physician Scientist Award
  • Research to Prevent Blindness Unrestricted Grant to Department of Ophthalmology
  • Hope Center for Neurological Disorders
  • Biotechnology and Biological Science Research Council (BBSRC; BB/N001842/1)
  • Washington University
  • Oriental Yeast Co.
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
nicotinamide mononucleotide, NAD biosynthesis, aging, anti-aging interventions, energy metabolism, insulin sensitivity, plasma lipid profile, weight gain, physical activity, eye function, mitochondrial oxidative metabolism, skeletal muscle
MeSH terms
Administration, Oral, Aging, Animals, Darkness, Drinking, Eating, Energy Metabolism, Food, Gene Expression Regulation, Insulin, Lipids, Lymphocytes, Male, Mice, Inbred C57BL, Mitochondria, NAD, Nicotinamide Mononucleotide, Physical Conditioning, Animal, Time Factors, Weight Gain, Bone Density, Muscle, Skeletal, Cell Respiration, Myeloid Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review